Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 2/20 | 0.51 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.45 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.45 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.45 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.45 |
| ▸ | MMP9 | P14780 | 1/20 | 0.44 |
| ▸ | MMP8 | P22894 | 1/20 | 0.44 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | HPGDS | O60760 | 2/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.43 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.43 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL346687 | 0.87 | FOLH1 (0.59) | ACECA1SLC7A5FOLH1MMP9 | |
| SCHEMBL8021425 | 0.87 | FOLH1 (0.59) | ACECA1SLC7A5FOLH1MMP9 | |
| SCHEMBL8374049 | 0.87 | FCER2 (0.50) | CA12CA1CA9MMP9MMP8 | |
| SCHEMBL468899 | 0.84 | ACE (0.55) | ACECA12CA1CA9SLC7A5 | |
| SCHEMBL6518708 | 0.84 | ACE (0.55) | ACECA12CA1CA9SLC7A5 | |
| SCHEMBL8842469 | 0.84 | ACE (0.52) | ACECA12CA1CA9SLC7A5 | |
| SCHEMBL23859819 | 0.84 | NPSR1 (0.56) | ESR1ESR2 | |
| SCHEMBL21117405 | 0.84 | MMP9 (0.55) | ACEFOLH1MMP9MMP8ESR1 | |
| SCHEMBL23859822 | 0.84 | NPSR1 (0.56) | ESR1ESR2 | |
| SCHEMBL15947340 | 0.82 | BACE1 (0.47) | ACEFOLH1MMP9MMP8ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-7300428-A | — | — | None | — | — | JP | disclosed |
| US-10406111-B2 | Gold/lanthanide nanoparticle conjugates and uses thereof | COLORADO SCHOOL OF MINES (US) | 2019-09-10 | — | — | US | disclosed |
| US-9382346-B2 | Gold nanoparticle conjugates and uses thereof | COLORADO SCHOOL OF MINES (US) | 2016-07-05 | — | — | US | disclosed |
| WO-2016082808-A1 | ORAL PREPARATION | USTAV MAKROMOLEKULARNI CHEMIE AV CR, V.V.I. (CZ) | 2016-06-02 | — | — | WO | disclosed |
| US-20160017065-A1 | Gold Nanoparticle Conjugates and Uses Thereof | COLORADO SCHOOL OF MINES | 2016-01-21 | — | — | US | disclosed |
| US-9175015-B2 | Gold nanoparticle conjugates and uses thereof | COLORADO SCHOOL OF MINES (US) | 2015-11-03 | — | — | US | disclosed |
| US-20150306256-A1 | Lanthanide Nanoparticle Conjugates and Uses Thereof | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION | 2015-10-29 | — | — | US | disclosed |
| US-20150258034-A1 | GOLD/LANTHANIDE NANOPARTICLE CONJUGATES AND USES THEREOF | COLORADO SCHOOL OF MINES | 2015-09-17 | — | — | US | disclosed |
| US-20150250902-A1 | pH-RESPONSIVE GADOLINIUM NANOPARTICLE CONJUGATES AND USES THEREOF | COLORADO SCHOOL OF MINES (US) | 2015-09-10 | — | — | US | disclosed |
| US-8968705-B2 | Gold/lanthanide nanoparticle conjugates and uses thereof | COLORADO SCHOOL OF MINES (US) | 2015-03-03 | — | — | US | disclosed |
| EP-0941123-A2 | DELIVERY OF NUCLEIC ACID MATERIAL TO TARGET CELLS IN BIOLOGICAL SYSTEMS | SCHACHT, Etienne Honoré (BE) | 1999-09-15 | — | — | EP | disclosed |
| US-5883211-A | Thermoreversible hydrogels comprising linear copolymers and their use in electrophoresis | ACLARA BIOSCIENCES, INC. (US) | 1999-03-16 | — | — | US | disclosed |
| WO-1998019710-A2 | DELIVERY OF NUCLEIC ACID MATERIAL TO TARGET CELLS IN BIOLOGICAL SYSTEMS | SCHACHT ETIENNE HONORE (BE) | 1998-05-14 | — | — | WO | disclosed |
| WO-1997040078-A1 | THERMOREVERSIBLE HYDROGELS COMPRISING NON-CROSSLINKED COPOLYMERS AND THEIR USE IN ELECTROPHORESIS | SOANE BIOSCIENCES (US) | 1997-10-30 | — | — | WO | disclosed |
| JP-H07300428-A | SYNTHETIC POLYMERIC DRUG | CESKOSLOVENSKA AKAD VED | 1995-11-14 | — | — | JP | disclosed |
| EP-0394400-B1 | POLYMER SUPERSURFACTANTS FOR PROTEIN RESISTANCE AND PROTEIN REMOVAL | UNIV UTAH (US) | 1995-07-12 | — | — | EP | disclosed |
| EP-0394400-A4 | POLYMER SUPERSURFACTANTS FOR PROTEIN RESISTANCE AND PROTEIN REMOVAL | — | 1991-12-27 | — | — | EP | disclosed |
| US-5075400-A | Water soluble polymers with polyethylene oxide sidechains; adsorbed on hydrophobic surfaces | UNIVERSITY OF UTAH (US) | 1991-12-24 | — | — | US | disclosed |
| EP-0394400-A1 | POLYMER SUPERSURFACTANTS FOR PROTEIN RESISTANCE AND PROTEIN REMOVAL. | UNIV UTAH (US) | 1990-10-31 | — | — | EP | disclosed |
| WO-1990003406-A1 | POLYMER SUPERSURFACTANTS FOR PROTEIN RESISTANCE AND PROTEIN REMOVAL | UNIVERSITY OF UTAH (US) | 1990-04-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150306256-A1 | Lanthanide Nanoparticle Conjugates and Uses Thereof | SSB, CD47, SLC6A13 | ACE 2911/4885CA12 53/4885CA1 360/4885 |
| US-20150258034-A1 | GOLD/LANTHANIDE NANOPARTICLE CONJUGATES AND USES THEREOF | SSB, LGALS9, LGALS3 | ACE 2712/4885CA12 70/4885CA1 665/4885 |
| US-10406111-B2 | Gold/lanthanide nanoparticle conjugates and uses thereof | SSB, LGALS9, LGALS3 | ACE 2712/4885CA12 70/4885CA1 665/4885 |
| US-20150250902-A1 | pH-RESPONSIVE GADOLINIUM NANOPARTICLE CONJUGATES AND USES THEREOF | GOLGA3, GDI1, CA13 | ACE 3986/4885CA12 11/4885CA1 54/4885 |
| US-20160017065-A1 | Gold Nanoparticle Conjugates and Uses Thereof | CD47, SELP, SELPLG | ACE 4059/4885CA12 296/4885CA1 1596/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.